Beginning in 2021, PNNL chemical physicist Bruce Kay begins a three-year term as an AVS trustee, part of a six-member committee responsible for overseeing the administration of student scholarships and major society awards.
A research team from Pacific Northwest National Laboratory developed an apparatus that evaluates the performance of high-temperature fluids in hydraulic fracturing for enhanced geothermal systems.
Researchers at Pacific Northwest National Laboratory (PNNL) are closer to understanding how iron may pave the way for sequestration of technetium-99 contaminants in the subsurface.
Researchers at PNNL have developed a bacteria testing system called OmniScreen that combines biological and synthetic chemistry with machine learning to hunt down pathogens before they strike.
The nation’s ability to test for COVID-19 has expanded, thanks to work at Pacific Northwest National Laboratory, where scientists have established the performance of testing equipment to detect the virus.
To study the impact of accelerated dryland expansion and degradation on global dryland gross primary production (GPP,) PNNL and Washington State University researchers assessed GPP data from 2000-2014 and the CMIP5 aridity index (AI).
Researchers from PNNL have helped colleagues at OHSU identify lipid molecules required for Zika infection in human cells. The specific lipids involved could also be a clue to why the virus primarily infects brain tissue.
Biomedical scientist Brian Thrall co-edited the issue published in the journal NanoImpact. Three of the articles in the issue include multiple PNNL authors.
Researchers from 25 institutions around the country, including PNNL, are working to find out how exercise changes the molecular makeup of our cells to generate health benefits.
PNNL computational biologist Bobbie-Jo Webb-Robertson was recently awarded the “Spirit of nPOD award” to acknowledge her hard work in building, coordinating, and leading the Data Science Working Group.
To help spur economic development and assist in the battle against COVID-19, PNNL is making available its entire portfolio of patented technologies on a research trial basis—at no cost—through the end of 2020.